EYPT
EyePoint Pharmaceuticals (EYPT)
$59
About EyePoint Pharmaceuticals (EYPT)
EyePoint Plc is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.
Details
Daily high
$12.83
Daily low
$12.07
Price at open
$12.69
52 Week High
$19.11
52 Week Low
$3.91
Market cap
1.1B
Dividend yield
0.00%
Volume
820,701
Avg. volume
1.5M
P/E ratio
-4.06
EyePoint Pharmaceuticals News
Details
Daily high
$12.83
Daily low
$12.07
Price at open
$12.69
52 Week High
$19.11
52 Week Low
$3.91
Market cap
1.1B
Dividend yield
0.00%
Volume
820,701
Avg. volume
1.5M
P/E ratio
-4.06